Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 6.12
-0.09 (-1.45%)
Jun 26, 2026, 4:10 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 324.7 million as of June 26, 2026.
Market Cap
324.70M
Enterprise Value
314.34M
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.12
Market Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 324.70M, an increase of 113.61%. That is a compound annual growth rate of 115.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 324.70M | 96.68% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 675.65M |
| Clinuvel Pharmaceuticals | 503.77M |
| Racura Oncology | 431.02M |
| Starpharma Holdings | 292.70M |
| Orthocell | 206.91M |
| Alterity Therapeutics | 121.80M |
| Actinogen Medical | 117.05M |
| Recce Pharmaceuticals | 115.67M |